严重急性肾损伤首次肾脏替代治疗:连续肾脏替代治疗与间断血液透析比较——AKIKI与IDEAL-ICU研究的二次分析
该研究为AKIKI与IDEAL-ICU两项多中心随机对照试验的二次分析,纳入早期RRT策略组543例严重AKI患者,按首次接受的RRT模式分为CRRT组269例与IHD组274例,采用倾向评分逆概率加权平衡混杂。加权后60天死亡率CRRT组54.4%、IHD组46.5%(加权HR 1.26,95%CI 1.01-1.60)。在SOFA评分3-10分的较轻患者中,IHD与更好的60天生存相关(加权HR 1.82,95%CI 1.01-3.28;p<0.01);更重患者中两种模式无生存差异证据。作者认为CRRT作为首次模式在生存或肾功能恢复方面似乎无获益,在病情较轻者中甚至可能结局更差,并提出应开展前瞻性随机非劣效试验。
要点
- 543例严重AKI患者中,首次RRT为CRRT者269例、IHD者274例;CRRT组心血管SOFA与总SOFA评分更高。
- 加权后60天死亡率CRRT组54.4% vs IHD组46.5%,加权HR 1.26(95%CI 1.01-1.60)。
- SOFA评分3-10分的较轻患者中,IHD与更好的60天生存相关(加权HR 1.82,95%CI 1.01-3.28;p<0.01)。
- 更重患者中未发现两种RRT模式存在生存差异的证据。
- 作者认为CRRT作为首次模式在生存或肾功能恢复方面似乎无获益,可能甚至与较轻患者更差结局相关。
适用人群与场景
- 两项多中心随机对照试验(AKIKI与IDEAL-ICU)中分配至早期RRT启动策略的严重AKI患者,共543例。
研究设计与关键结果
- 研究类型:AKIKI与IDEAL-ICU两项多中心随机对照试验的二次分析;纳入早期RRT策略组患者,按首次接受的RRT模式分组(CRRT组269例,IHD组274例),以60天总生存为主要终点,采用倾向评分逆概率加权进行主要分析。
- CRRT组患者心血管SOFA评分与总SOFA评分更高;逆概率加权后所有预设混杂因素在组间达到充分平衡。
- 加权Kaplan-Meier 60天死亡率:CRRT组54.4% vs IHD组46.5%(加权HR 1.26,95%CI 1.01-1.60)。
- SOFA评分3-10分的较轻患者中,接受IHD与更好的60天生存相关(加权HR 1.82,95%CI 1.01-3.28;p<0.01)。
- 更重患者中未发现两种RRT模式存在生存差异的证据。
证据类型、等级与局限
- 证据类型:两项多中心随机对照试验(AKIKI与IDEAL-ICU)的二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,与IHD相比,CRRT作为首次RRT模式在生存或肾功能恢复方面似乎无获益,在病情较轻(SOFA评分3-10分)的患者中甚至可能结局更差。
- 作者建议开展前瞻性随机非劣效试验,以解决最佳RRT技术这一持续存在的难题。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Intermittent hemodialysis (IHD) and continuous renal replacement therapy (CRRT) are the two main RRT modalities in patients with severe acute kidney injury (AKI). Meta-analyses conducted more than 10 years ago did not show survival difference between these two modalities. As the quality of RRT delivery has improved since then, we aimed to reassess whether the choice of IHD or CRRT as first modality affects survival of patients with severe AKI.
METHODS: This is a secondary analysis of two multicenter randomized controlled trials (AKIKI and IDEAL-ICU) that compared an early RRT initiation strategy with a delayed one. We included patients allocated to the early strategy in order to emulate a trial where patients would have been randomized to receive either IHD or CRRT within twelve hours after the documentation of severe AKI. We determined each patient's modality group as the first RRT modality they received. The primary outcome was 60-day overall survival. We used two propensity score methods to balance the differences in baseline characteristics between groups and the primary analysis relied on inverse probability of treatment weighting.
RESULTS: A total of 543 patients were included. Continuous RRT was the first modality in 269 patients and IHD in 274. Patients receiving CRRT had higher cardiovascular and total-SOFA scores. Inverse probability weighting allowed to adequately balance groups on all predefined confounders. The weighted Kaplan-Meier death rate at day 60 was 54·4% in the CRRT group and 46·5% in the IHD group (weighted HR 1·26, 95% CI 1·01-1·60). In a complementary analysis of less severely ill patients (SOFA score: 3-10), receiving IHD was associated with better day 60 survival compared to CRRT (weighted HR 1.82, 95% CI 1·01-3·28; p < 0.01). We found no evidence of a survival difference between the two RRT modalities in more severe patients.
CONCLUSION: Compared to IHD, CRRT as first modality seemed to convey no benefit in terms of survival or of kidney recovery and might even have been associated with less favorable outcome in patients with lesser severity of disease. A prospective randomized non-inferiority trial should be implemented to solve the persistent conundrum of the optimal RRT technique.
参考来源
- Gaudry S, Grolleau F, Barbar S, et al. Continuous renal replacement therapy versus intermittent hemodialysis as first modality for renal replacement therapy in severe acute kidney injury: a secondary analysis of AKIKI and IDEAL-ICU studies. Crit Care. 2022. PMID: 35379300. doi:10.1186/s13054-022-03955-9
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。